Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05218733Phase 4Completed
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Ain Shams University. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05218733.